FTO and cervical cancer: Moreover, when distributed all cervical cancer patients according to their clinical stage, we observed a dramatically higher FTO’s expression in late stage patients (stage III and IV) compared to early stage patients (stage I and II) as well as normal cervices, suggesting upregulation of FTO was usually correlated with cervical cancer progression (Fig. 1c).